Hemophilia A

Name

Hemophilia A

Accession Number

DBCAT003233

Description

Not Available

Drugs

Drug	Drug Description
Antihemophilic factor human	A Factor VIII replacement therapy used to treat hemophilia A.
Antihemophilic factor, human recombinant	A form of recombinant coagulation Factor VIII used to treat hemophilia A, von Willebrand disease, and Factor XIII deficiency.
Humate-P	Not Annotated

Drugs & Drug Targets

Drug	Target	Type
Antihemophilic factor human	Coagulation factor IX	target
Antihemophilic factor human	Coagulation factor X	target
Antihemophilic factor human	Vitamin K-dependent protein C	enzyme
Antihemophilic factor, human recombinant	Coagulation factor X	target
Antihemophilic factor, human recombinant	Phytanoyl-CoA dioxygenase, peroxisomal	target
Antihemophilic factor, human recombinant	Coagulation factor IX	target
Antihemophilic factor, human recombinant	Asialoglycoprotein receptor 2	target
Antihemophilic factor, human recombinant	78 kDa glucose-regulated protein	target
Antihemophilic factor, human recombinant	Calreticulin	target
Antihemophilic factor, human recombinant	Calnexin	target
Antihemophilic factor, human recombinant	Protein ERGIC-53	target
Antihemophilic factor, human recombinant	Prolow-density lipoprotein receptor-related protein 1	target
Antihemophilic factor, human recombinant	Multiple coagulation factor deficiency protein 2	target
Antihemophilic factor, human recombinant	von Willebrand factor	target
Antihemophilic factor, human recombinant	Prothrombin	enzyme
Antihemophilic factor, human recombinant	Vitamin K-dependent protein C	enzyme